Compare IDEXX Laboratories, Inc. (IDXX) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Toyota Motor Corp — how do they compare? IDEXX Laboratories, Inc. trades at $521.77 (market cap $40.43B), while Toyota Motor Corp trades at $184.76 (market cap $217.38B). The key difference: Toyota Motor Corp is far larger — about 5.4× IDEXX Laboratories, Inc.'s market cap, and Toyota Motor Corp pays a 3.37% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Toyota Motor Corp for 116 Days on average.
| IDXX | TM | |
|---|---|---|
Market Cap | $40.43B | $217.38B |
Volume | 692,164 | 291,250 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $248.29 |
52-Week Low | $504.70 | $166.50 |
Typical Hold Time | 46 Days | 116 Days |
Enterprise Value | $41.32B | $410.96B |
Dividend Yield | — | 3.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
Toyota Motor trades at $185.17, up 1.24% with a bearish technical signal despite strong fundamentals. The stock shows attractive valuation metrics with a P/E of 8.38 and P/S of 0.73, while delivering consistent earnings beats in recent quarters. Recent news highlights strong U.S. sales performance and electrification progress, though technical indicators show selling pressure with key support at $184.
Toyota presents a value opportunity with solid profitability and clean balance sheet, though near-term headwinds include China sales weakness and production disruptions. Analyst consensus leans cautious with 62.5% hold ratings, reflecting concerns about profit margin compression despite the company's market leadership and electrification investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
